USC University Hospital and the USC Division of Cardiology have developed a pulmonary hypertension program for the evaluation and treatment of patients with primary and secondary forms of pulmonary hypertension (high blood pressure in the arteries that supply the lungs).

The program includes advanced invasive and noninvasive testing for pulmonary hypertension as well as treatment using intravenous prostacyclin therapy (FLOLAN). Treatment with experimental agents is available through the Pulmonary Hypertension Program for patients meeting certain entry criteria.

The program has a pulmonary hypertension nurse coordinator to help with referrals, transfers, patient education and support and initiation of therapy. Patients started on FLOLAN at USC University Hospital undergo care, evaluation and teaching to promote successful therapy with this potentially life saving but difficult drug.

A social worker with expertise in problems related to pulmonary hypertension is part of the team and helps with issues of support, access to care and resources. Access to and evaluation for lung and heart/lung transplantation in collaboration with the Transplant program is also available.